| Literature DB >> 29977374 |
Felix Scheidt1, Christian Thiehoff1, Gülay Yilmaz1, Stephanie Meyer1, Constantin G Daniliuc1, Gerald Kehr1, Ryan Gilmour1.
Abstract
Herein, we describe a catalytic fluorooxygenation of readily accessible N-allylcarboxamides via an I(I)/I(III) manifold to generate 2-oxazolines containing a fluoromethyl group. Catalysis is conditional on the oxidation competence of Selectfluor®, whilst HF serves as both a fluoride source and Brønsted acid activator. The C(sp3)-F bond of the mono-fluoromethyl unit and the C(sp3)-O bond of the ring are aligned in a synclinal relationship thereby engaging in stabilising hyperconjugative interactions with vicinal, electron-rich σ-bonds (σC-C→σ*C-F and σC-H→σ*C-O). This manifestation of the stereoelectronic gauche effect was established by X-ray crystallographic analysis of a representative example. Given the importance of fluorine in drug discovery, its ability to modulate conformation, and the prevalence of the 2-oxazoline scaffold in Nature, this strategy provides a rapid entry into an important bioisostere class.Entities:
Keywords: catalysis; cyclisation; fluorination; gauche effect; hypervalent iodine; oxazolines
Year: 2018 PMID: 29977374 PMCID: PMC6009682 DOI: 10.3762/bjoc.14.88
Source DB: PubMed Journal: Beilstein J Org Chem ISSN: 1860-5397 Impact factor: 2.883
Figure 1Selected examples of bioactive compounds containing the 2-oxazoline motif.
Figure 2The catalytic difluorination of alkenes (top) and the proposed fluorocyclisation via the same I(I)/I(III) manifold (bottom).
Optimisation of reaction conditions for a benchmark transformation (1→2).a
| Entry | Concentration | Solvent | Catalyst loading | Amine/HF ratio | Conversionb | Yield |
| 1 | 0.2 | DCE | 20 | 1:4.5 | >95 | 46 |
| 2 | 0.2 | DCE | 20 | 1:3 | 50 | <5 |
| 3 | 0.2 | DCE | 20 | 1:7.5 | >95 | 44 |
| 4 | 0.2 | DCE | 20 | 1:9.23 | >95 | 46 |
| 5 | 0.2 | DCE | 20 | Pyr·HF | >95 | 27 |
| 6 | 0.1 | DCE | 20 | 1:4.5 | >95 | 81 |
| 7 | 0.1 | toluene | 20 | 1:4.5 | >95 | 72 |
| 8 | 0.1 | MeCN | 20 | 1:4.5 | 78 | 47 |
| 9 | 0.1 | THF | 20 | 1:4.5 | 34 | <5 |
| 10 | 0.1 | DCM | 20 | 1:4.5 | >95 | >95 |
| 12 | 0.1 | DCM | 2.5 | 1:4.5 | 40 | 30 |
| 13 | 0.1 | DCM | 0 | 1:4.5 | <5 | <5 |
aStandard reaction conditions: N-allylbenzamide (200 µmol), catalyst p-iodotoluene, solvent, amine/HF source 1:1 (v/v), Selectfluor® (1.5 equiv), ambient temperature, 24 h; bDetermined from the 1H NMR spectrum using ethyl fluoroacetate (1.0 equiv) as internal standard; cDetermined from the 19F NMR spectrum using ethyl fluoroacetate (1.0 equiv) as an internal standard; dReaction conducted with 1 mL of solvent; eYield after column chromatography on silica gel. Reduction in yield is due to hydrolysis. DCE: 1,2-dichloroethane.
Figure 3Substrate scope. aReaction conducted on 1 mmol scale. bReaction time increased to 40 hours. cReaction time increased to 32 hours. Yields refer to isolated values whilst NMR yields are given in parentheses (19F NMR using ethyl fluoroacetate as an internal standard).
Scheme 1Exploring diastereocontrol and the synthesis of the fluorohydrin 3. Yields in parentheses were determined by 19F NMR using ethyl fluoroacetate as an internal standard. Unless otherwise stated, yields refer to isolated values.
Figure 4X-ray molecular structure of compound 2c. Thermal ellipsoids shown at the 50% propability level. Torsion angle (F1–C10–C9–O1 −73.4°) consistent with the fluorine gauche effect. CCDC number 1815371.
Crystallographic data for compound 2c.
| Entry | Data |
| formula | C10H9FN2O3 |
| 224.19 | |
| crystal size, mm3 | 0.032 × 0.162 × 0.247 |
| crystal system | orthorhombic |
| space group | |
| cell constants | |
| 10.0315(3) | |
| 15.4164(5) | |
| 6.5161(2) | |
| 1007.71(5) | |
| 4 | |
| 1.48 | |
| μ, mm−1 | 1.06 |
| 464 | |
| 100(2) | |
| λ, Å | 1.54178 |
| 2θmax, deg | 137 |
| transmissions | 0.78–0.97 |
| refl. meas./indep./ | 10003/1813/0.034 |
| ref. parameters | 182 |
| restraints | 118 |
| 0.032 | |
| 0.086 | |
| 1.05 | |
| Δρmax, e Å−3 | 0.145/−0.194 |